Itamar gets injection of capital
FRAMINGHAM, Mass. – Viola Private Equity has committed to invest up to $28.4 million in Itamar Medical, the manufacturer of the WatchPAT home sleep test. “An investment of $30 million will enhance the execution of Itamar Medical's growth strategy and the leveraging of the many financial opportunities we are identifying in the market,” said Gilad Glick, CEO of Itamar Medical, in a release. Viola Private Equity, an Israeli-based technology growth capital and buyout fund,will become the largest shareholder of Itamar, according to terms of the deal. Jonathan Kolber and Sami Totah, both general partners at Viola Private Equity, will join Itamar Medical's board of directors.